SLS
#1796
SELLAS Life Sciences Group, Inc. - Common Stock
13.3 4 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.98%
Changement Mensuel
+33.40%
Evolution sur 6 mois
+183.83%
Changement Annuel
+594.79%
Clôture Précédente
13.2 1
Open
13.3 4
Low
13.3 4
High
13.3 4
Volume
134
Financials
- Market Capitalization 2.69 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1762 |  ALMS Alumis Inc. - Common Stock | 21.81 USD | -2.55% | -7.27% | -21.24% | +383.59% | 2.82 B USD | ||
| 1789 |  ATAI AtaiBeckley Inc. - Common Stock | 7.34 USD | +0.69% | -0.54% | +2.23% | +85.82% | 2.72 B USD | ||
| 1800 |  NRIX Nurix Therapeutics, Inc. - Common stock | 25.78 USD | -1.64% | -3.52% | +12.28% | +129.97% | 2.68 B USD | ||
| 1818 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 23.16 USD | +0.35% | -3.82% | +23.19% | +3.16% | 2.62 B USD |